Serum Hormone and Metabolic Levels in a Woman With Insulin-Resistant PCOS and Metabolic Syndrome Who Received Long-Term GnRH Analogue Therapy Before Bilateral Salpingo-Oophorectomy for Massively Enlarged Ovaries
Laboratory Test . | Patient Value . | Normal Value . |
---|---|---|
Aspartate aminotransferase, U/L | 162 | <36 |
Alanine aminotransferase, U/L | 339 | <45 |
Fasting glucose, mg/dL | 91 | <100 |
2-h postprandial glucose, mg/dL | 187 | <140 |
Fasting insulin, µU/mL | 56 | <25 |
2-h postprandial insulin, µU/mL | 598 | 41 |
Total cholesterol, normal, mg/dL | 237 | <200 |
Low-density lipoprotein, mg/dL | 130 | <130 |
High-density lipoprotein, mg/dL | 29 | >50 |
Triglycerides, mg/dL | 388 | <150 |
Total T after GnRH analogue, ng/dL | 10 | <45 |
Free T after GnRH analogue, pg/mL | 1.4 | <6.4 |
Laboratory Test . | Patient Value . | Normal Value . |
---|---|---|
Aspartate aminotransferase, U/L | 162 | <36 |
Alanine aminotransferase, U/L | 339 | <45 |
Fasting glucose, mg/dL | 91 | <100 |
2-h postprandial glucose, mg/dL | 187 | <140 |
Fasting insulin, µU/mL | 56 | <25 |
2-h postprandial insulin, µU/mL | 598 | 41 |
Total cholesterol, normal, mg/dL | 237 | <200 |
Low-density lipoprotein, mg/dL | 130 | <130 |
High-density lipoprotein, mg/dL | 29 | >50 |
Triglycerides, mg/dL | 388 | <150 |
Total T after GnRH analogue, ng/dL | 10 | <45 |
Free T after GnRH analogue, pg/mL | 1.4 | <6.4 |
Bold laboratory values are elevated compared to the normal range for each respective category.
Serum Hormone and Metabolic Levels in a Woman With Insulin-Resistant PCOS and Metabolic Syndrome Who Received Long-Term GnRH Analogue Therapy Before Bilateral Salpingo-Oophorectomy for Massively Enlarged Ovaries
Laboratory Test . | Patient Value . | Normal Value . |
---|---|---|
Aspartate aminotransferase, U/L | 162 | <36 |
Alanine aminotransferase, U/L | 339 | <45 |
Fasting glucose, mg/dL | 91 | <100 |
2-h postprandial glucose, mg/dL | 187 | <140 |
Fasting insulin, µU/mL | 56 | <25 |
2-h postprandial insulin, µU/mL | 598 | 41 |
Total cholesterol, normal, mg/dL | 237 | <200 |
Low-density lipoprotein, mg/dL | 130 | <130 |
High-density lipoprotein, mg/dL | 29 | >50 |
Triglycerides, mg/dL | 388 | <150 |
Total T after GnRH analogue, ng/dL | 10 | <45 |
Free T after GnRH analogue, pg/mL | 1.4 | <6.4 |
Laboratory Test . | Patient Value . | Normal Value . |
---|---|---|
Aspartate aminotransferase, U/L | 162 | <36 |
Alanine aminotransferase, U/L | 339 | <45 |
Fasting glucose, mg/dL | 91 | <100 |
2-h postprandial glucose, mg/dL | 187 | <140 |
Fasting insulin, µU/mL | 56 | <25 |
2-h postprandial insulin, µU/mL | 598 | 41 |
Total cholesterol, normal, mg/dL | 237 | <200 |
Low-density lipoprotein, mg/dL | 130 | <130 |
High-density lipoprotein, mg/dL | 29 | >50 |
Triglycerides, mg/dL | 388 | <150 |
Total T after GnRH analogue, ng/dL | 10 | <45 |
Free T after GnRH analogue, pg/mL | 1.4 | <6.4 |
Bold laboratory values are elevated compared to the normal range for each respective category.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.